Evaluation of Thermotherapy for the Treatment of Cutaneous Leishmaniasis in Kabul, Afghanistan: A Randomized Controlled Trial

被引:41
作者
Safi, Najibullah [1 ]
Davis, Gary D. [2 ]
Nadir, Mohammed [3 ]
Hamid, Hamida [4 ]
Robert, Leon L., Jr. [5 ]
Case, Alan J. [2 ]
机构
[1] UNOCA Compound, World Hlth Org Country Off, Dept Primary Hlth Care, Kabul, Afghanistan
[2] Combined Training Advisory Grp Army CSTC A, NATO Training Mission Afghanistan NTM A, MTAG, APO, AE 09356 USA
[3] UNOCA Compound, World Hlth Org Country Off, Communicable Dis Surveillance & Response Dept, Kabul, Afghanistan
[4] Res Dept, Natl Malaria & Leishmaniasis Control Program, Kabul, Afghanistan
[5] US Mil Acad, Dept Chem & Life Sci, West Point, NY 10996 USA
关键词
D O I
10.7205/MILMED-D-11-00161
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anthroponotic cutaneous leishmaniasis (CL) is a common cause of ulcerative lesions and disfiguring scarring among children in Afghanistan. Most lesions occur on the face and are commonly caused by the trypanosome protozoan parasite Leishmania tropica, transmitted by the bite of an infected sandfly (Phlebotomus sergenti). This study compared the effectiveness of a single localized treatment with thermotherapy to 5 days of intralesional administration of Glucantime for the treatment of CL. Three hundred and eighty-two patients with CL were randomly assigned to the two treatment groups and followed for 6 months. The cure rate for the thermotherapy group was 82.5%, compared to 74% in the Glucantime group. The authors concluded that a single localized treatment with thermotherapy was more effective than 5 days of intralesional administration of Glucantime. Additionally, thermotherapy was more cost-effective, with fewer side effects, of shorter duration, and with better patient compliance than intralesional Glucantime.
引用
收藏
页码:345 / 351
页数:7
相关论文
共 18 条
[1]  
[Anonymous], 2002, WORLD HLTH REPORT 20, P186
[2]   CUTANEOUS LEISHMANIASIS IN KABUL - OBSERVATIONS ON A PROLONGED EPIDEMIC [J].
ASHFORD, RW ;
KOHESTANY, KA ;
KARIMZAD, MA .
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1992, 86 (04) :361-371
[3]   A policy for leishmaniasis with respect to the prevention and control of drug resistance [J].
Bryceson, A .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2001, 6 (11) :928-934
[4]  
Central Statistics Office of the Islamic Republic of Afghanistan, 2003, COMP THERM RAD INTR
[5]  
Croft SL, 2002, CURR PHARM DESIGN, V8, P273
[6]   Leishmaniasis - Public health aspects and control [J].
Desjeux, P .
CLINICS IN DERMATOLOGY, 1996, 14 (05) :417-423
[7]   The increase in risk factors for leishmaniasis worldwide [J].
Desjeux, P .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2001, 95 (03) :239-243
[8]   Pentavalent Antimonials: New Perspectives for Old Drugs [J].
Frezard, Frederic ;
Demicheli, Cynthia ;
Ribeiro, Raul R. .
MOLECULES, 2009, 14 (07) :2317-2336
[9]   Interventions for Old World cutaneous leishmaniasis [J].
Gonzalez, Urba ;
Pinart, Mariona ;
Reveiz, Ludovic ;
Alvar, Jorge .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (04)
[10]  
Griffiths W. A. D., 1987, The leishmaniases in biology and medicine. Volume II. Clinical aspects and control, P617